Yankton Community Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 920 Broadway Ave Ste 2, Yankton, SD 57078 Phone: 605-260-0310 |
Allpoints Yankton Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 409 Summit St, Suite 3400, Yankton, SD 57078 Phone: 605-260-0310 |
Lewis & Clark Family Medicine Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 2525 Fox Run Parkway, Ste 200, Yankton, SD 57078 Phone: 605-260-2100 Fax: 605-665-5200 |
Yankton Family Planning Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 317 Broadway Ave, Ste 8, Yankton, SD 57078 Phone: 605-665-8838 Fax: 605-665-1123 |
Yankton Medical Clinic Pc Clinic/Center Medicare: Medicare Enrolled Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 |
Avera Medical Group Family Medicine Yankton Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2525 Fox Run Pkwy Ste 200, Yankton, SD 57078 Phone: 605-260-2100 Fax: 605-260-2104 |
James D Kerr Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 613 Walnut St, Yankton, SD 57078 Phone: 605-660-9958 Fax: 605-689-3101 |
Family Medicine Clinic Of Yankton Professional Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 1000 West 4th Street, Suite 15 Family Medicine Clinic Of Yankton Prof Llc, Yankton, SD 57078 Phone: 605-665-0555 Fax: 605-665-4498 |
Sacred Heart Health Services Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 W 4th St Ste 8, Yankton, SD 57078 Phone: 605-655-1201 |
News Archive
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has commenced an underwritten registered public offering of shares of its common stock. All of these shares are being sold by Idenix.
Children's Hospital of Philadelphia celebrates a pivotal moment in medicine: approval by the European Commission of LUXTURNA (voretigene neparvovec), the first and only gene therapy for patients with an inherited retinal disease, last month.
According to a major drug manufacturer, a combination drug treatment appears to be effective in fighting breast cancer that has spread to the brain.
Everyone wonders what bugs might be lurking in public bathrooms. Now researchers are using novel genetic sequencing methods to answer this question, revealing a plethora of bacteria all around, from the doors and the floors to the faucet handles and toilet seats, with potential public health implications, as reported Nov. 23 in the online journal PLoS ONE.
› Verified 7 days ago